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Background: This protocol presents a systematic residential treatment- and research program aimed at patients
who have not responded adequately to previous treatment attempts. Patients included in the program primarily
suffer from anxiety and/or depressive disorders and usually from one or more comorbid personality disorders. The
treatment program is time-limited (eight weeks) and has its basis in treatment principles specified in intensive
short-term dynamic psychotherapy (ISTDP). This treatment modality is theoretically well-suited for the handling of
various forms of treatment resistance presumably central to these patients’ previous non-response to psychological
and psychiatric interventions.
Methods/Design: The research component of the project entails a naturalistic longitudinal research design which
aims at systematic evaluation of the effectiveness of the program. To our knowledge, this is one of the first
treatment programs and corresponding research projects that systematically select patients with previous non- or
negative response to treatment and subjects them to a broad and comprehensive, but theoretically unified and
consistent treatment system.
Discussion: The present paper introduces the project, describes its theoretical and methodological underpinnings,
and discusses possible future implications and contributions of the project. It thereby serves as a comprehensive
background reference to future publications from the project.Background
It is a well known fact that the majority of patients in psy-
chiatric care respond inadequately to the treatments they
are given. This is exemplified in large scale psychotropic
medication trials (See STAR-D study). In general, using
the notion of effect size [1] most empirically validated psy-
chotherapy treatments tend to help about half of treated
patients to a substantial or moderate degree, and about
a further quarter of patients to some extent, while the
remaining patients usually continue unchanged or are to
some extent deteriorated [2]. Using the criteria of clinically
significant change [3], the average recovery rate for formal
psychotherapeutic treatments in clinical trials (based on* Correspondence: o.a.solbakken@psykologi.uio.no
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distribution, and reproduction in any mediummeta-analytic studies across a wide variety of psycho-
logical treatment models and formats) is between 50 and
60 per cent [2]. Consequently, by this definition, as much
as 40 to 50 per cent of patients remain, in terms of clinic-
ally meaningful change, unimproved or are worsened at
termination. The known deterioration rates from such tri-
als are relatively consistent and indicate that five to ten
per cent of patients participating report themselves as reli-
ably worse off after treatment than before [2]. In what is
often denoted routine care, i.e. treatment as it is delivered
in naturalistic settings without specific supervision of ther-
apists and specific systems for focusing the delivered treat-
ments, the rates of recovery appear to be smaller, so that
even more patients are expected to remain unchanged or
deteriorate in everyday psychotherapeutic practice [4].
We thus have a situation in which a relatively large pro-
portion of patients in mental health care must be classified
as non-responders or negative responders, i.e. they do not
benefit from the treatments with which they are provided,d Central Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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fairs is, or at least should be, distressing to mental health
professionals and psychotherapy researchers alike, and any
chance of remedying it should be a highly valuable contri-
bution to the mental health care community and the many
patients seeking treatment.
There has been very limited research on patients who
don’t respond to psychotherapy. It therefore remains
largely unknown whether changes in treatment formats,
treatment dose, or treatment content could improve out-
come for at least a portion of these patients. However, in-
direct knowledge of this group comes from studies on the
treatment of patients with personality disorders [5-8],
from studies of non-response to antidepressant medica-
tion for depression [9], and from studies of the effects of
process-outcome feedback systems on patient responses
to treatment [2]. Generally, the findings indicate that the
probability of non-response or negative response increases
with more severe symptoms, with more profound func-
tional impairment, with more problems in interpersonal
relatedness, and with the presence of personality disorder.
Problem complexity as evidenced by comorbidity on Axis
I and/or II and problem chronicity also appears to predict
treatment failure in short-term treatments and has been
proposed as an indicator for more complex and broad-
band treatment [10]. From studies on session by session
feedback to therapists and patients about treatment re-
sponse through monitoring levels of self-reported distress,
interpersonal problems, and social role functioning at the
beginning of every session, it does, however, appear to be
clear that such feedback reduces the prevalence of nega-
tive change in psychotherapy, thereby increasing overall
effectiveness of treatments [2].
Reviewing the literature, it becomes clear that few studies
have selected patients from the group of non-responders
to psychotherapy for systematic intervention and scientific
investigation. Furthermore, to our knowledge, no studies
have specifically selected patients primarily based on re-
peated non-response to treatment and attempted system-
atic, customized psychotherapeutic intervention with this
group. Such studies could yield important knowledge
about the possibilities of finding feasible strategies for over-
coming this unfortunate state of affairs. If it was possible to
identify specific principles of customized treatment that
could lead to better outcomes of psychotherapeutic inter-
vention for patients belonging to this group, it would imply
significant relief and increase in quality of life for a large
number of patients. It could also result in considerable
social-economic savings associated with reduced treatment
costs and lower reliance on welfare services for a substan-
tial number of those disabled by persistent and unrelenting
mental disorders not responsive to traditional treatments.
Accordingly, the current project was designed and imple-
mented. With the aim of relieving the suffering of patientshaving experienced repeated non-response to treatment ef-
forts, a time-limited residential treatment program was de-
vised. The project was based at the psychodynamic unit at
“Thorsberg”, the Residential Facility of the Drammen Dis-
trict Psychiatric Center, Norway. The treatment program
was primarily directed towards relieving treatment resistant
anxiety- and depressive disorders with and/or without
comorbid Axis II disorder. This group of patients presum-
ably represents the majority of non-responding or treat-
ment resistant referrals (due to the prevalence of these
disorders). As a criterion of inclusion, patients were to have
received three or more qualified and documented treatment
attempts, defined as separate medical or psychosocial/psy-
chotherapeutic treatment series aimed at the disorder(s) for
which they currently were referred for treatment.
Considering the long-standing and chronic disorders
suffered by these patients and their often years-long treat-
ment histories, it was clear that the treatment program
would have to be organized according to fundamentally
different principles than those guiding routine care. First,
it was decided that patients were to be treated in residen-
tial care in order to increase the probability of treatment
compliance (in the medical sense of the word) and reduce
the risk of drop-out. Secondly, a clear and non-debatable
time limit was provided, with a circumscribed date for ter-
minating treatment for all patients (at the end of eight
weeks of residential treatment). Thirdly, a highly intensive
treatment and intervention program was devised with
multiple treatment components delivered every day.
The treatment program was to extensively combine indi-
vidual psychotherapy, group-psychotherapy, medical/psy-
chopharmacological treatment (if necessary), and various
therapeutic activities in groups including body aware-
ness training, art therapy, structured psycho-education,
moderate physical exercise, psychosocial training, and
milieu therapy. As a theoretical system to inform sys-
tematic understanding of patients and all treatment compo-
nents, the psychotherapeutic model and metapsychology
originally described by Davanloo [11] (Intensive Short-term
Dynamic Psychotherapy, ISTDP), along with the more gen-
eral affect theoretical model delineated by affect integration
theory [12,13] were chosen. This meant that a fundamental
understanding of psychopathology as failed integration of
affect, cognition, and behavior was adhered to, with a speci-
fied focus on the mobilization of warded off, repressed, or
avoided affect associated with pathogenic ruptures to the
patient’s bonds with attachment figures throughout the
course of development.
Arguably, Davanloo’s ISTDP is the psychotherapy model
in the literature today that most clearly conceptualizes sys-
tematic work with treatment resistance, at least in the trad-
itional psychodynamic sense of that word. ISTDP posits a
conceptually integrated and extensive set of interventions
and intervention modes that are specifically directed at
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or unconsciously resort to in order to avoid genuine emo-
tional closeness, to water down strong affect, to remain
passive, compliant, or defiant and so on and so forth.
These processes presumably contribute substantially to
the generation of obstacles to treatment and consequent
treatment failure if not effectively and specifically dealt
with. For this reason we chose to use the technical inter-
vention apparatus described and detailed by Davanloo and
others (e.g. [14,15]) as a basis for the individual psycho-
therapy courses, and to use adjusted and adapted versions
of this system for guiding intervention in other compo-
nents of the treatment.
In general, ISTDP is a fairly well documented treatment
for a number of mental disorders. It has been demon-
strated to be clinically effective and cost-effective in case
series of mixed psychiatric samples [16,17]. Also, it has
been shown to be effective and cost effective with a previ-
ous (but small) sample of patients with treatment resistant
depression [18], in personality disorder [5,19-21], and in a
specialized hospital setting for treating severe cases of bor-
derline personality disorder, most of which had had previ-
ous treatment but failed to benefit [22]. It has been studied
in resistant and complex populations in several case series
and randomized controlled trials [19]. It has been dem-
onstrated in the National Health Services in the UK’s
“Pathfinder” project to produce good treatment effects in
patients resistant to other treatment efforts [23]. It has
been found effective for patients with chronic somatic
conditions with functional movement disorders [24], with
chronic pain [25] and with medically unexplained symp-
toms with repeated emergency visits [26]. Thus, there is a
fairly good empirical basis for choosing the ISTDP model
as a basis for a treatment program aimed at relieving the
suffering of patients characterized by non-response to pre-
vious treatment attempts.
The treatment philosophy and treatment principles of
ISTDP have been described in detail elsewhere, e.g.
[5,11,15,22]. Here it suffices to say that the main em-
phasis of ISTDP is to rapidly help the patient acknow-
ledge, identify, experience, and express unconscious and
warded-off affects or emotions that theoretically are pos-
tulated to produce unconscious anxiety, symptom distur-
bances, and various defensive strategies that become
interpersonally maladaptive and may produce character-
ological disturbances within the patient. The main tech-
nical interventions are to detect, clarify and challenge
affect-avoiding strategies or defenses in systematic collab-
oration with the patient, while inviting and encouraging
clear awareness and deep experience of warded-off feel-
ings. This process, when effectively executed, mobilizes
what Davanloo called “complex transference feelings” with
the therapist, thereby actualizing the patient’s most press-
ing patterns of attachment-related affect and his mostcharacteristic coping strategies with these affects within
the therapeutic relationship. Simultaneously, the conscious
and unconscious therapeutic alliance is mobilized, produ-
cing a force within the patient that allies with the therapist
in the face of avoidance strategies and resistances [11]. In
turn, this leads to a reduction in defensive coping so that
the patient can more directly work through unresolved
feelings related to broken attachments in the past and sub-
sequent trauma [5].
The treatment program and its quality control system
were designed so that comprehensive and reliable data
would be available for determining the ultimate effect-
iveness of the treatments delivered. Such documentation
was seen to be paramount in order to justify the rela-
tively large investments of resources and money that is
necessary for offering residential care for patients that
statistically would be likely to fail also this treatment. A
substantial number of process- and outcome indicators
were therefore implemented as standard procedure. This
quality control system implied that all individual treat-
ment sessions were to be videotaped, the systematic use of
diagnostic and functional interviews prior to, at termination
and follow-up after termination, and that an extensive bat-
tery of self-report measures were to be administered prior
to treatment, during treatment, and after treatment. Fur-
thermore, a system for session-by-session process and pro-
gress tracking was to be implemented, so that therapists
would have continuous feedback about the development of
all patients. The follow-up period post treatment termin-
ation was defined to be at least 12 months. The research
relevance of this data was immediately acknowledged;
therefore a research protocol was detailed that was to hold
international standards in terms of assessment procedures
and methodological design.
The data gathered through the “Drammen Project” are
unique in that they combine the selection of a group of
patients previously not systematically investigated in the
established literature, while at the same time delivering a
multifaceted treatment program of unusual intensity based
on a treatment model that appears especially well-suited
for the task of relieving treatment resistance. These data
thus carry potentially important insights that may be
highly valuable to both psychotherapy research and the
psychotherapy community.
Main research objectives for the Drammen project
The following research objectives can be detailed as be-
ing at the heart of the research part of the Drammen
Project for treating patients with treatment resistant
mental disorders.
1. What is the effectiveness of an intensive
multifaceted time limited treatment program based
on principles from ISTDP for patients with known
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follow-up after treatment?
2. Which process-outcome mechanisms may foster or
conversely hinder adequate treatment response for
patients entering the program?
3. Which patient- and therapist factors predict poor
and good response for patients entering the
program?
Methods/Design
Treatment setting and location
Treatment is provided at the Psychodynamic Unit at
“Thorsberg”, the Residential Facility at the Drammen
District Psychiatric Center, Norway. This unit was devel-
oped and founded with the task of managing difficult-to-
treat conditions through intensive, time-limited in-patient
care. The unit has room for a total of six patients, each re-
ceiving an eight week “block” treatment program. Thus,
groups of up to six patients enter and terminate treatment
simultaneously. Each year a total of five groups or “blocks”
are treated with a maximum total of 30 patients per
annum.
Recruitment procedures
Patients are recruited among referrals for in-patient
psychiatric care at the residential treatment facility of
the Drammen District Psychiatric Center. Patients are
referred partly by practitioners at local out-patient psy-
chiatric clinics, nearby psychiatric hospitals, and by gen-
eral practitioners in the Drammen area. Patients are
initially screened for the inclusion/exclusion criteria by
the intake-team at the residential facility, before complet-
ing an evaluation session with one of the treatment pro-
viders at the psychodynamic ward. The evaluator reaches
a final decision regarding inclusion/exclusion on the bases
of prior treatment history, existing diagnostic information,
referral information, and the patients’ responses to inter-
vention in the evaluation session. Patients who are offered
treatment at the ward are then informed about the study
and invited to participate. If patients are willing and eli-
gible to participate, signed and informed consent is ob-
tained after comprehensive explanation of the procedures
of the project. Participants do not receive compensation in
any form for evaluation, screening, or assessments. Partici-
pating in the assessment-procedures is obligatory as part
of internal quality control for patients receiving the treat-
ment program, however participation in research project
is voluntary.
Participating patients
Inclusion criteria
Adult patients (aged 18–70) are eligible to participate
if they a.) Fulfill basic criteria of need for hospitalization
for psychiatric treatment including insufficient generalfunctioning and loss of mastery/function in multiple do-
mains, e.g. inadequate self-care, substantial breakdown in
relational, occupational, and/or personal functioning. b.)
There are clear indications of prior treatment resistance, i.e.
previous failure to respond adequately (in terms of signifi-
cant symptomatic relief and increased functioning) in three
or more prior treatment attempts for the current episode/
ongoing psychiatric disease. The number of three previous
attempts were chosen to increase the likelihood that in-
cluded patients had severe and truly treatment resistant
disorders, rather than previous non-response being attrib-
utable to chance factors, or the delivery of poor or unsuit-
able treatment. And c.) The patient demonstrates signs of
capacity for taking an intrapsychic perspective on own
problems during the evaluation session, i.e. the ability to
regard one’s problems as the result of difficulties in dealing
with feelings, thoughts, and reactions to self/others. All
three criteria are to be fulfilled for inclusion. Co morbid
axis-I and axis-II disorders are allowed, as is medication
with the exception of continuous intake of sedatives.
Exclusion criteria
Patients are excluded from the study if they suffer from
one or more of the following disorders; a psychotic
disorder (except short, reactive psychotic episodes), bi-
polar disorder type I, dissociative identity disorder, ad-
diction of such severity that detoxification is indicated
(after which entering treatment is possible), psychiatric
disorders secondary to medical conditions, mental re-
tardation, or insufficient command of the Norwegian
language hindering the utilization of treatment. Also,
acute suicide risk and history of severe acting out/
problems with impulse control are considered contra-
indications to participation.
Therapists
All therapists providing individual treatment in the pro-
gram are trained and certified psychologists. With the ex-
ception of one psychologist who left the unit soon after
the program was started, all therapists participate in a
three-year core training in ISTDP (Intensive Short-Term
Dynamic Psychotherapy) including supervision of video-
taped therapy sessions. The core training program is de-
livered in Norway by internationally renowned tutors
organized and directed by Jon Frederickson, Washington
School of Psychiatry, US. In addition to Frederickson the
team of tutors consists of Kees Cornelissen, PTC De
Viersprong, Netherlands, and Professor Allan Abbass,
Dalhousie University, Canada. In addition, the thera-
pists take part in bimonthly group supervisions with
Professor Allan Abbass. Finally, peer supervision takes
place on a weekly basis in the unit. The level of experi-
ence of individual therapists is highly variable ranging
from 2 to over 30 years.
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trained, and certified in traditional psychodynamic group
psychotherapy and have co-developed the synthesis of
ISTDP-principles and traditional group therapeutic ideas
adhered to in the program. The body awareness in-
structor/physiotherapist is highly experienced, specialized
and certified in psychomotor physiotherapy. Finally, the
therapist administering art therapy is certified and highly
experienced in this modality.Table 1 Weekly treatment activities for patients included
in the program
Activity Duration
(minutes)
Weekly
sessions
Individual psychotherapy* 50 2
Group psychotherapy* 90 2
Body awareness training* 60 1
Art therapy* 90 1
Physical exercise 120 2
Lectures* 60 1
Day planning in plenum* 30 5
Consultation with
miljeu-therapist/primary contact*
45 1
Group based social activity/training 120 3
Psychomotor physiotherapy (optional)* 45 (1)
Consultation with social/occupational
therapist (optional)
45 (1)
Arts and crafts workshop (optional) 120 (1)
Note. *Specifically tailored be in keeping with ISTDP-treatment principles.The treatment program
The treatment program is an eight week residential
intervention, within these eight weeks a number of treat-
ment components are delivered; the majority of which
are actively integrated within the theoretical frameworks
of ISTDP [11] and affect integration theory [12]. Patients
enter the program in groups of up to six patients (mini-
mum four), each member of a group enters treatment at
the same time and terminates eight weeks later. Patients
receive either two weekly individual single sessions (45 mi-
nutes) or one weekly double session (90 minutes) depend-
ing on their capacity for tolerating intensive, relatively
long-lasting pressure and focus toward the experiencing of
warded off feelings.
All individual therapists were educated and trained in
the basic principles of ISTDP, and instructed to adhere
to these principles in individual sessions. Treatment in-
tegrity and adherence to ISTDP-principles are continu-
ously checked in the bimonthly group supervisions with
Professor Allan Abbass. Also, videotapes of all individual
sessions are available for systematic adherence and com-
petence evaluation.
Patients also receive two weekly group sessions 90 mi-
nutes each. These group sessions integrate the notion of
pressure to feeling, and systematic clarification and chal-
lenge of defenses, with traditional group therapeutic prin-
ciples [27]. There are also weekly body awareness training
groups based on principles from psychomotor physiother-
apy, along with bi-weekly low-intensity physical exercise
(walking), and weekly psycho-educational lectures provid-
ing a conceptual understanding of the therapeutic process.
Finally, all patients take part in weekly art therapy groups
focusing on the experience and expression of feelings
through creative and artistic displays. Individual psycho-
motor therapy is an optional addition offered to all pa-
tients at the start of treatment.
Beyond the individual therapist, all patients are pro-
vided a primary treatment contact among the ward staff
with whom they are encouraged to discuss important
aspects of their development and potential challenges
for the therapeutic process in a systematic and continu-
ous fashion. The primary contact and other staff also
implement treatment principles from ISTDP wheneversuitable and indicated in the every day on-goings within
the ward. Table 1 summarizes the weekly treatment ac-
tivities of the program.
Scientific design
The research project is a naturalistic longitudinal study
for examining the short- and long term effectiveness of
this time-limited intensive in-patient treatment pro-
gram for relieving treatment resistant conditions,
mainly anxiety-, depressive-, and personality disorders.
To increase confidence in our findings a naturalistic
waitlist control condition is established. Thus, patients
are assessed with self-rated measures prior to their
evaluation session so that development from the time
of evaluation until the onset of treatment can be used
as a contrast to effects presumably attributable to the
treatment itself. In the treatment and follow-up phases,
observer- and self-rated assessments are done in the
week prior to hospitalization (T1), during the eight
week treatment phase (t01-t08), at termination (T2), in
addition to six (T3) and twelve months (T4) after the
end of treatment. Individual psychotherapy sessions
are videotaped for supervision purposes and made
amenable to the application of observational coding
systems for rating various process and outcome factors
in treatment.
Assessments and assessment schedule
Observer rated measures
Experienced members of staff are specifically trained for
assessing patients included in the treatment program on
the relevant observer based measures which are con-
ducted prior to hospitalization (T1), at termination (T2),
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Neuropsychiatric Interview [28] is used for assessing Axis
I diagnoses. The Structured Clinical Interview for the
Diagnostic and Statistical Manual of Mental Disorders,
Axis II, Fourth Edition (DSM-IV-R) (SCID-II) [29] is used
for assessing Axis II personality disorders and severity of
personality problems. Finally, the Affect Consciousness
Interview (ACI) [30] is used for assessing the functional
level of affect integration and affect organization.
The MINI neuropsychiatric interview The Mini Inter-
national Neuropsychiatric Interview [28] was developed to
meet the need for a brief, reliable and valid structured diag-
nostic interview for screening a variety of psychiatry disor-
ders and replacing the somewhat cumbersome Structured
Clinical Interview for DSM-IV-R, Axis I (SCID I) and the
Composite International Diagnostic Interview (CIDI) in
clinical trials. The MINI contains 120 questions and screens
16 Axis I and one Axis II DSM IV-R disorders for 24
current and lifetime diagnoses. Like the SCID-P and CIDI,
the MINI is organized in diagnostic sections. Using branch-
ing tree logic, the MINI has two to four screening questions
per disorder. Additional symptom questions within each
disorder section are asked only if the screen questions are
positively endorsed. Since anxiety and depressive disorders
are a central focus of the program, the presence or absence
of such disorders will be used as specific measures of out-
come from the treatment, along with diagnostic status on
other relevant diagnostic categories in the MINI.
The structured clinical interview for the diagnostic
and statistical manual of mental disorders, axis II
(SCID-II) The SCID II [29] is a version of the SCID de-
veloped for the assessment of DSM-IV-TR Personality
Disorders. The interview covers the eleven DSM-IV Per-
sonality Disorders (including Personality Disorder NOS)
and the appendix categories Depressive Personality Dis-
order and Passive-Aggressive Personality Disorder. It
closely follows the language of the DSM-IV Axis II Per-
sonality Disorders criteria. The scoring is done so that
the trait either is absent, sub-threshold, true, or there is
“inadequate information to code”. Traits considered true
are then summed up and diagnoses are indicated when
the required number of traits are present for any given
disorder. The SCID-II is administered by trained inter-
viewers and generally yields decent indications of the
personality disorder spectrum.
The Affect Consciousness Interview (ACI) The ACI is
a semi-structured interview designed for assessing the
consciousness and integration of discrete affects (Affect
Consciousness - AC) [30,31]. Five aspects of the experi-
ence of these affects are assessed: Scenes/elicitors, aware-
ness, tolerance, emotional (nonverbal) expression andconceptual (verbal) expression. The interviewer asks about
the following for each affect: (1) scenes in which the affect
is activated, (2) how the patient becomes aware of and rec-
ognizes the affect, (3) how the affect impacts upon the pa-
tient, how the patient copes with the affect, and what
information the patient decodes from the affect activation,
(4) to what extent and how the affect is expressed in non-
verbal forms (i.e., emotional expression, a category that re-
fers to the respondent’s consciousness of own voluntary
and involuntary nonverbal expressions) and finally (5) to
what extent and how the affect is expressed verbally (i.e.,
conceptual expression). The interviews are administered
by trained interviewers, videotaped, and scored according
to criteria specified in the Affect Consciousness Scales
(ACSs) [30]. The ACSs comprise four specified nine-step
scales, one for each of the integrative aspects: Awareness,
Tolerance, Emotional Expression and Conceptual Expres-
sion. A score of 1 is the lowest possible, 9 is the highest,
and a score of 5 would be considered normal. On the
basis of these indicators, scores on three different levels
are calculated: Overall mean score (Global AC), mean
score on each of the four integrating aspects (e.g., the
mean Awareness-score across the nine affects), and
mean score on each of the specific affects (e.g., mean
score on awareness, tolerance, emotional expression
and conceptual expression for Tenderness/Care).Self rated measures
A number of self-rated questionnaires are completed
prior to the evaluation session, prior to treatment onset,
and throughout the treatment- and follow-up phases,
reflecting various aspects of patient functioning and
therapeutic process. One questionnaire assesses basic
demographic information, along with information on
prior treatment, educational level, current occupational
status, the use of medications, and current financial
situation. As a principle measure of level of psychopath-
ology and psychological functioning, as well as a process
measure reflecting weekly improvement/deterioration
the Outcome Questionnaire- 45 (OQ-45) is used [32].
The OQ-45 is first administered before the evaluation
session, in the week before onset of treatment, and then
before every single individual psychotherapy session
throughout the treatment phase, as well as six and twelve
months after termination. In addition, the Symptom
Checklist 90-Revised [33] (SCL-90-R), and the Inventory
of Interpersonal Problems (IIP-64) [34] are used prior to
evaluation, before onset of treatment, in weeks two and
five of treatment, at termination, and six and twelve
months after termination. The Working Alliance Inven-
tory, patient version (WAI-P) [35] is used as a measure of
conscious working alliance and is administered in week
two, five, and at termination.
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symptom and distress inventory developed by Lambert
et al. [32]. It has been found to be useful for examining
the effectiveness of psychotherapy over time [36]. The in-
strument is designed to assess “patient functioning” and
scores are used to track changes in symptomatology on a
session-by-session basis. The OQ-45 consists of 45 items
tapping various aspects of psychological distress each as-
sociated with a 5-point Likert scale. Responses refer to the
last seven days and range from “never” to “almost always”.
Once responses to nine negatively worded items have
been reverse-coded, sum scores are calculated with higher
scores representing increasing levels of psychopathology.
Overall scores are calculated along with scores on each of
three subscales, assessing Symptom Distress (SD), Social-
Role functioning (SR) and Interpersonal Relationships (IR)
respectively.
Symptom checklist-90-revised (SCL-90-R) The SCL-
90-R is a widely used and comprehensive symptom inven-
tory that measures symptom distress on nine dimensions
and three global indexes [33]. Intensity of 90 symptoms
during the last seven days is rated on a five point Likert
scale ranging from not at all (0) to very much (4). The
Global Severity Index (GSI), the average score across all
90 items, is regarded a highly nuanced and valuable indi-
cator of overall current level of distress [37]. The primary
symptom dimensions that are assessed are somatization,
obsessive-compulsive, interpersonal sensitivity, depression,
anxiety, hostility, phobic anxiety, paranoid ideation, psy-
choticism, and a category of “additional items” assessing
other aspects of patient symptoms such as sleep distur-
bances, guilt/self-blame, and eating/appetite problems.
The depression-, anxiety-, and phobic anxiety- subscales
will be used as specific outcome measures of these, to the
program, central outcome dimensions.
Inventory of interpersonal problems (IIP-64) General
and specific interpersonal problems are assessed using the
64 item IIP-circumplex version [34]. The IIP-64 consists of
two types of items. The first 39 items begin with the phrase:
“It is hard for me to…” The remaining 25 items represent
“Things that you do too much.” Each item is rated on a five
point Likert scale ranging from not at all (0) to very much
(4). The general or elevation factor of the IIP-64 has been
consistently linked to both symptom severity and negative
affectivity [38]. The second (Agency) and third (Commu-
nion) factors, yielding the IIP-64 circumplex structure, gen-
erally show good construct validity in terms of fit with a
quasi-circumplex model, along with distinct convergent-
discriminant correlation patterns with different forms of
personality pathology, supporting the notion that the IIP-
64 model adequately represents its theoretically alleged
distinctions in interpersonal functioning [31,39]. Theoverall score of the IIP-64 is used as an indicator of
general interpersonal problems. The IIP-64 also yields
eight octant sum-scores indicating specific problems
with being PA=Domineering/Controlling, BC =Vindictive/
Self-Centered, DE =Cold/Distant, FG = Socially Inhibited,
HI =Non-Assertive, JK =Overly Accommodating, LM=
Self-Sacrificing and NO= Intrusive/Needy.
The working alliance inventory (WAI) Patient rated
working alliance is assessed by the Working Alliance In-
ventory (WAI) [31] short version with 12 items rated on a
seven point scale [40]. The WAI covers three aspects of
working alliance: therapeutic bond, task, and goal. The
goals subscale assesses the extent to which patient and
therapist agree on the goals that are the target of the inter-
vention. The tasks subscale assesses the extent to which
patient and therapist agree on the in-counseling behaviors
and ideas that form the substance of the counseling
process. The bond subscale assesses the extent to which
patient and therapist share mutual trust, acceptance, and
confidence in the process at hand. Table 2 summarizes the
assessment instruments and assessment schedule.
Sample size and data analytic strategies
Sample size
The research project is designed to include a minimum
of 250 patients; however, all patients treated at the unit
are invited to participate, so the sample size is expected
to increase further over time.
Statistical power
In research where demonstrating the effectiveness of treat-
ment is an objective, statistical power will always be an im-
portant factor. Exact estimation of statistical power is only
possible for specific analytic designs aimed at delimited re-
search questions and necessarily based on conditions that
are not exhaustively known when a study is initiated. How-
ever, in general a sample of 250 patients will yield a statis-
tical power of .80 for the detection of small to medium
effect sizes for the overall effect in one-way analyses of
variance. This means that the probability of detecting sig-
nificant differences between points of measurement is 80%
for an effect size (Cohens’s d) greater than 0.3 -0.5. This es-
timate will also apply to change scores between to points
of measurement if we assume that the average correlation
between time-points is greater than .50. In pair-wise com-
parison of subgroups with n = 80 the probability of detect-
ing small to medium effects similarly will be about .80.
Data analytic strategies
The data from the project lends itself to various research
topics. Most centrally, the data can contribute valu-
able knowledge on the effectiveness of short-term and
time-limited residential treatment for treatment resistant
Table 2 Overview of assessment instruments and assessment schedule in the treatment and follow-up phases
T1 T01-08 T2 T3 T4
Clinical and diagnostic interviews
MINI 5.0, Axis I diagnoses (symptom disorders) X X X
SCID-II, Axis II diagnoses (personality disorders) X X X
The affect consciousness interview (ACI) X X X
Background information
Historical background and previous treatments X X X
Use of medications X X X X
Work, education, and financial situation X X X
Symptoms
Symptom check List 90- R, SCL-90-R X X X X X
Outcome questionnaire- 45, OQ-45 X X X X X
Interpersonal functioning
The inventory of interpersonal problems-64 (IIP-64) X X X X X
Therapeutic alliance
Working alliance inventory-short patient (WAI-S-P) X X X
Note. T1 = pre treatment, T01-08 = sessions 1 through eight during treatment, T2 = termination, T3 = 6 months post treatment, T4 = 12 months post treatment.
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tion using continuous outcome variables (e.g. OQ-45,
IIP-64, AC) multilevel (or hierarchical linear) modeling
will be applied using the linear mixed models module in
the SPSS/PASW, version 18.0. The application of multi-
level modeling for the analysis of longitudinal data, in
this case repeated measurements on the same individ-
uals, is strongly recommended in the literature [41,42].
For longitudinal data, measurements are nested within
individuals, so that measurements represent units at the
first level and individuals represent units at the second.
It is usually proposed that as requirements for longitu-
dinal analyses, all variables must be collected at three or
more measurement waves, that a continuous outcome
changes systematically over time, and that a meaningful
unit for time is included [42]. Each of these require-
ments is met by the design of the present project. Gene-
rally, based on experiences with previous patients going
through the program we expect low attrition rates. Al-
most all patients are expected to complete the treatment
program and deliver data for the complete treatment
phase. Some attrition is expectable for the follow-phase,
but here to, based on previous experience, we expect
that as much as 80 – 90% will deliver follow-up data at least
on one occasion.
Using Cohen’s [1] formula, effect sizes can be calculated
as the growth-curve estimated difference between end-
status and baseline divided by the pooled standard deviation
across all measurement points of the relevant outcome vari-
able. For dichotomous outcome variables (e.g. presence or
absence of Axis I and II disorders) treatment effects will be
tested with simpler survival analysis and cross tabulation.Treatment response for individual patients on self-
rated instruments is defined in terms of clinically signifi-
cant change (CSC) according to Jacobson and Truax [3].
Thus, we will identify the number of patients that are re-
liably improved and have moved from the dysfunctional
to the functional range (recovered), the number of pa-
tients reliably improved but not recovered, the number
of patients reliably worsened, and the number of patients
unchanged on central outcome measures.
The data also lend themselves to a number of investiga-
tions into the conceptual and empirical relationships
between various measures of psychological health and
functioning, and to tests of the psychometric properties of
different measures included in the study, e.g. on the rela-
tionship between symptom patterns and interpersonal
problem types, on the validity of the subscales of the
OQ-45 and the SCL-90-R and so on and so forth. For such
investigations traditional exploratory and semi-confirmatory
factor analyses, multiple linear regression models, and
correlation analyses will be performed. Finally, data may
prove to be a valuable source of information on the pre-
dictors of change and treatment response when treating
treatment resistant patients. For answering research ques-
tions related to this topic, individual growth curves will be
utilized and relevant predictors entered into the multilevel
models of change.
Research ethical considerations
Participation in the research part of the program is volun-
tary. Participants are informed that they can withdraw
their consent to participate at any time without disclosing
reasons for their cancellation. There are no negative
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livered. All participants sign a written and informed con-
sent. The protocol for the study was evaluated by the
Regional Committee for Medical and Health Research
Ethics in Eastern Norway and a letter of exemption was
issued classifying the study as a quality control project
approving dissemination of results.
Discussion
The Drammen Project has as its core a systematic treat-
ment program directed at patients who have not profited
adequately from previous treatment attempts. Included
patients primarily suffer from anxiety or depressive dis-
orders, and usually, but not always, from comorbid per-
sonality disorders. The treatment program is time-limited
and based in treatment principles from intensive short-
term dynamic psychotherapy, a treatment modality that
theoretically is well-suited for the handling of various
forms of treatment resistance presumably central to these
patients’ previous non- or negative response to therapy.
The project furthermore entails a naturalistic longitudinal
research design which systematically evaluates the effect-
iveness of the treatment program. To our knowledge, this
is the first treatment program and corresponding research
project that systematically selects patients with previous
non- or negative response to treatment and subjects them
to a broad and comprehensive, but theoretically unified
and consistent treatment system. The project thus carries
the potential of yielding important and novel knowledge
about the treatment of non-responders to psychiatric care
and the potential for succeeding with them through inten-
sive and systematic intervention. Furthermore, the pro-
gram is one of very few that applies principles from
ISTDP across a variety of treatment components within a
residential setting. Results from the Drammen Project will
thus be a valuable complement to the promising findings
already reported on residential ISTDP [22].
The protocol presented here gives an in depth description
of the treatment program and the corresponding research
design. It offers a comprehensive source of background in-
formation pertinent to the Drammen Project and any pub-
lications that will arise from it. It thus will serve as a central
reference that contains more detailed information on the
methodological and design qualities of the project than is
possible in later research publications and make these qua-
lities available for critical review.
Strengths and limitations
The Drammen Project does meet many requirements for a
sound observational longitudinal treatment study. The
number and quality of assessment instruments are gene-
rally high and there is a systematic combination of obser-
vational and self-rated measures. Assessments are done at
a large number of occasions, increasing the reliability ofmeasurements. The data collected are well suited for hier-
archical or multilevel modeling approaches [42], making
modern and powerful data analytic strategies for longitu-
dinal data feasible. Patients are assessed not only prior to,
during and at treatment termination, but also during a
follow-up period of reasonable duration. Furthermore, the
group of patients selected for the project has not previously
been studied systematically, but represent an important
sub-population of treatment takers that suffer substantially
despite seeking and receiving treatment. The project also
will generate data for a fairly large number of patients and
will comprise a relatively large number of therapists. As
the treatments are implemented in a naturalistic setting
within the Norwegian public health care system we have
reason to believe that results should generalize to other
naturalistic treatment settings, i.e. other residential treat-
ment institutions if similar systems were to be imple-
mented there.
One limitation of the project is its inability to differenti-
ate the effects of various sub-components of the treatment
program. It is thus impossible to discern whether effects
are generated primarily by certain components of the pro-
gram (individual treatment, group therapy etc.), or by the
synergy of all components. Likewise, it is impossible to dis-
cern the effects of theory specific therapeutic factors, such
as those entailed by the ISTDP- treatment framework, and
the effects of general or common therapeutic factors such
as a safe environment for self-disclosure, warmth, trust, re-
spect, corrective emotional experience, exposure, support,
psycho-education etc. However, the effectiveness of the en-
tire treatment system will be demonstrable.
There is no active control condition, nor randomization
of subjects, so it is not possible to show the efficacy of this
treatment compared to other relevant treatment systems
or to treatment as usual (TAU). Such studies would con-
stitute a valuable and important continuation of the work
started here. However, the selection of patients on the
basis of previous treatment failure does imply an inherent
form of control condition. In previous qualified attempts
of treatment these patients have failed to respond ad-
equately, thus significant effects detected in the present
program will indicate at least indirectly the efficacy of the
program as compared to treatment as usual. Also, the use
of waiting list data as a naturalistic control condition in-
creases the credibility of findings from the project.
Possible contributions to the field of knowledge
There are primarily two valuable contributions to the lit-
erature that may result from the Drammen Project. Firstly,
it can demonstrate the effectiveness of specialized inter-
vention for patients suffering from treatment resistant dis-
orders. If the Drammen projects and its intervention
system prove to be effective, this will have implications for
treatment providers in mental health care across many
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stration of such effects could form the basis for new stu-
dies aimed at identifying mechanisms of change for this
group on a larger scale. The Drammen Project also will
generate substantial data which on their own may shed
light on the question of process-outcome relationships in
the treatment of treatment resistant disorders. Likewise,
patient and therapist predictors of treatment response in
this group can be identified, along with significant infor-
mation on the pre-treatment characteristics of treatment
resistant patients in general.
Secondly, the Drammen Project may demonstrate the
utility of a broad scoped intervention system based on
ISTDP in a residential setting. Prior investigations into the
effectiveness of ISTDP and ISTDP-based treatments have
been conducted in out-patient settings situated outside of
public health care systems, with the exception of the work
done by Cornelissen and his collegues in the Netherlands
[22]. Thus, the present project can complement previous
research by adding knowledge about residential ISTDP
with a different patient population and implemented in
another residential facility in another public health care
system than has been the case in previous research.
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